Find clinical trials for Non-Hodgkin Lymphoma in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma

B-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

Leukemia

Lymphoid Leukemia

B-Cell Chronic Lymphocytic Leukemia

Cancer

Non-Hodgkin Lymphoma trials near Indianapolis, IN, USA:

Study of IMPT-314 in R/R Aggressive B-cell NHL

This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...

Enrolling

Relapsed Non-Hodgkin Lymphoma

Refractory Non-Hodgkin Lymphoma

Drug: IMPT-314

Phase 1, Phase 2

ImmPACT Bio

Indianapolis, Indiana, United States of America and 14 other locations

A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma (SUNMO)

participants with relapsed or refractory (R/R) diffuse-large B-cell lymphoma (DLBCL), high-grade B-cell lymphoma, transformed folli...

Active, not recruiting

Non-Hodgkin Lymphoma

Drug: Tocilizumab

Drug: Gemcitabine

Phase 3

Roche

Noblesville, Indiana, United States and 62 other locations

WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma

Phase 1, open-label, multicenter study of WTX-330 administered as a monotherapy to patients with advanced or metastatic solid tumors or non- ...

Enrolling

Non-Hodgkin Lymphoma

Advanced or Metastatic Solid Tumors

Drug: WTX-330

Phase 1

Werewolf Therapeutics

Indianapolis, Indiana, United States and 8 other locations

Status recently updated

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

in participants with relapsed or refractory (R/R) solid tumors or non-Hodgkin lymphoma (NHL).Part 2: Cohort Expansion. The...

Enrolling

Active, not recruiting

Non-Hodgkin Lymphoma

Relapsed Solid Tumors

Drug: KB-0742

Phase 1, Phase 2

Kronos Bio

Indianapolis, Indiana, United States and 24 other locations

Locations recently updated

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of this stud...

Enrolling

Non-Hodgkin's Lymphoma

Diffuse Large B-Cell Lymphoma

Drug: ABBV-525

Phase 1

AbbVie

Indianapolis, Indiana, United States and 28 other locations

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

20-expressing Non-Hodgkin lymphoma....

Enrolling

Primary Mediastinal Large B Cell Lymphoma

Marginal Zone Lymphoma

Drug: Fludarabine

Drug: Cyclophosphamide

Phase 1

Acepodia Biotech

Indianapolis, Indiana, United States and 6 other locations

Locations recently updated

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

is focused on participants with previously untreated follicular lymphoma. Follicular lymphoma is a type of non-Hodgkin...

Enrolling

Follicular Lymphoma (FL)

Drug: Odronextamab

Drug: Vincristine

Phase 3

Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 68 other locations

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma (OLYMPIA-1)

is focused on participants with previously untreated follicular lymphoma (a type of non-Hodgkin lymphoma or NHL)....

Enrolling

Follicular Lymphoma (FL)

Drug: Odronextamab

Drug: Rituximab

Phase 3

Regeneron Pharmaceuticals

Noblesville, Indiana, United States and 129 other locations

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic-...

Enrolling

Classic Follicular Lymphoma

Diffuse Large B-Cell Lymphoma

Drug: Epcoritamab

Phase 2

Genmab

Indianapolis, Indiana, United States and 70 other locations

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma (OLYMPIA-3)

The study is focused on patients with diffuse large B-cell lymphoma (DLBCL) that have not been treated before (called "previously untreated"...

Enrolling

Diffuse Large B-cell Lymphoma (DLBCL)

Drug: Doxorubicin

Drug: Prednisone/Prednisolone

Phase 3

Regeneron Pharmaceuticals

Indianapolis, Indiana, United States and 141 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms

Find clinical trials for Non-Hodgkin Lymphoma in .css-epvm6{white-space:nowrap;}Indianapolis, IN

Related conditions:

Non-Hodgkin Lymphoma trials near Indianapolis, IN, USA:

Study of IMPT-314 in R/R Aggressive B-cell NHL

A Study Evaluating Efficacy and Safety of Mosunetuzumab in Combination With Polatuzumab Vedotin Compared to Rituximab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma (SUNMO)

WTX-330 in Patients With Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphoma

A Study of KB-0742 in Participants With Relapsed or Refractory Solid Tumors Including Platinum Resistant High Grade Serous Ovarian Cancer (HGSOC)

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

ACE1831 in Adult Subjects With Relapsed/ Refractory CD20-expressing B-cell Malignancies

A Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma (OLYMPIA-2)

A Trial to Learn if Odronextamab is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Different Types of Chemotherapy for Participants With Follicular Lymphoma (OLYMPIA-1)

A Study to Evaluate Adverse Events of Subcutaneous (SC) Epcoritamab Administered in the Outpatient Setting in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Classic Follicular Lymphoma

A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Patients With Previously Untreated Diffuse Large B-cell Lymphoma (OLYMPIA-3)

Find clinical trials for Non-Hodgkin Lymphoma in Indianapolis, IN